Amino Gmbh, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is L-ASPARTIC ACID, with a corresponding US DMF Number 34525.
Remarkably, this DMF maintains an Active status since its submission on January 27, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 27, 2024, and payment made on March 22, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II